Published in Vaccine Weekly, February 27th, 1995
Kenneth Miller et al. investigated the clinical relevance of antibody responses to melanoma vaccine immunization in 108 patients with surgically resected, stage III malignant melanoma ("Improved Survival of Patients with Melanoma with an Antibody Response to Immunization to a Polyvalent Melanoma Vaccine," Cancer, January 15, 1995;75(2):495-502).
"The study was conducted with a polyvalent melanoma antigen vaccine constructed from surface material shed into culture...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly